A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars: An ISPOR Special Interest Group Report-Reference-Cited by-同舟云学术

A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars: An ISPOR Special Interest Group Report

Published:2023-08 Issue:8 Volume:26 Page:1137-1144
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Moorkens Evelien,Lacosta Teresa Barcina,Dawoud Dalia,Inotai András,Janodia Manthan,Tan Chia Jie,Lim Ka Keat,Khatri Nishtha,Pereira Catarina Lopes,Simoens Steven

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference87 articles.

1. Policy practices to maximise social benefit from biosimilars;Inotai;J Bioequiv Availab,2017

2. Economic evaluation of biosimilars for reimbursement purposes - what, when, how?;Moorkens;J Mark Access Health Policy,2020

3. Biosimilars: key regulatory considerations and similarity assessment tools;Kirchhoff;Biotechnol Bioeng,2017

4. Regulatory frameworks for marketing authorisation of biosimilars: where do we go from here?;Moorkens;European Pharmaceutical Law review,2018

5. Biosimilaires : de la technique au médicoéconomique

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful implementation of interchange of biologic medications in chronic arthritis after information of costs to prescribers;Exploration of Musculoskeletal Diseases;2024-09-10

2. Mapping Health Technology Assessment Agency Approaches for Biosimilar Value Assessment: An ISPOR Special Interest Group Report;Value in Health;2024-05

3. Leveraging the holistic benefits of biosimilars in Europe – part 2: how payers can safeguard the future of a healthy biosimilar market environment;Expert Review of Pharmacoeconomics & Outcomes Research;2024-02-12

4. Short and long-term economic implications of biosimilars;Expert Opinion on Biological Therapy;2024-01-19